Subject: MRR
Immunology Market to grow at a CAGR of 8.45% by 2025|Insights on Emerging Trends, Opportunities & New Product Launches | 17000+ Technavio Reports
NEW YORK, Nov. 29, 2021 /PRNewswire/ -- The "Immunology Market - Competitive Analysis, Drivers, Challenges & Five Force Analysis" report has been added to Technavio's offering. The immunology market is estimated to grow by USD 55.00 billion from 2020 to 2025, growing at a CAGR of 8.45% as per the latest report by Technavio.
For more insights on Immunology Market - Download a free sample now!
40% of the market's growth will originate from North America. The US is a key market for immunology in the region. The growing cases of infectious diseases will facilitate the immunology market growth in North America. The report offers an up-to-date analysis of the geographical composition of the market, competitive intelligence, and regional opportunities in store for vendors.
Market Dynamics
Factors such as growing organ transplantation will be crucial in driving the growth of the market. However, the entry of biosimilars will restrict market growth. The holistic analysis of the drivers will help in predicting end goals and refining marketing strategies to gain a competitive edge.
Company Profiles
The immunology market is fragmented and the vendors are deploying various organic and inorganic growth strategies to compete in the market. The immunology market report provides complete insights on key vendors including AbbVie Inc., Amgen Inc., Bristol-Myers Squibb Co., F. Hoffmann-La Roche Ltd., Johnson and Johnson Inc., Novartis AG, Pfizer Inc., Sumitomo Dainippon Pharma Co. Ltd., Takeda Pharmaceutical Co. Ltd., and UCB SA.
Few Companies with Key Offerings
- AbbVie Inc. - The company offers immunology products namely HUMIRA.
- Amgen Inc. - The company offers immunology products namely IMLYGIC.
- Bristol-Myers Squibb Co - The company offers immunology products namely ORENCIA.
Competitive Analysis
The competitive scenario provided in the immunology market report analyzes, evaluates, and positions companies based on various performance indicators. Some of the factors considered for this analysis include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, growth in market share, etc.
Market Segmentation
- By Category, the market is classified as immunosuppressants and immuno boosters. The immunology market share growth by the immunosuppressants segment has been significant.
- By Geography, the market is classified as North America, Europe, Asia, and ROW. North America will have the largest share of the market.
Related Reports -
Biotechnology Reagents Market -The biotechnology reagents market size is expected to reach a value of USD 32.11 billion, at a CAGR of 7.39%, during 2021-2025. Download a free sample now!
Cell Viability Assays Market -The cell viability assays market size has the potential to grow by USD 1.40 billion during 2020-2024, and the market's growth momentum will accelerate during the forecast period. Download a free sample now!
Immunology Market Scope | |
Report Coverage | Details |
Page number | 120 |
Base year | 2020 |
Forecast period | 2021-2025 |
Growth momentum & CAGR | Accelerate at a CAGR of 8.45% |
Market growth 2021-2025 | USD 55.00 billion |
Market structure | Fragmented |
YoY growth (%) | 8.01 |
Regional analysis | North America, Europe, Asia, and ROW |
Performing market contribution | North America at 40% |
Key consumer countries | US, Germany, UK, China, and Japan |
Competitive landscape | Leading companies, competitive strategies, consumer engagement scope |
Companies profiled | AbbVie Inc., Amgen Inc., Bristol-Myers Squibb Co., F. Hoffmann-La Roche Ltd., Johnson and Johnson Inc., Novartis AG, Pfizer Inc., Sumitomo Dainippon Pharma Co. Ltd., Takeda Pharmaceutical Co. Ltd., and UCB SA |
Market Dynamics | Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, market condition analysis for the forecast period |
Customization purview | If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
SOURCE Technavio
These press releases may also interest you
|
News published on and distributed by:
